2017 annual financial data
ImmunityBio 2017 Operating margin
Direct answer
Operating margin was -220,266.67%.
Operating income was -99,120,000 USD and net income was -96,423,000 USD.
Operating cash flow was -48,780,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,000 USD
- Operating income
- -99,120,000 USD
- Net income
- -96,423,000 USD
- Operating cash flow
- -48,780,000 USD